ArticleFrontiers in public health2024
A study on cognitive trajectory changes and predictive factors in middle-aged and older adults individuals with dual sensory impairment based on the health social determinants model.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Paid work participation and cognitive function trajectories among older adults in China: evidence from a longitudinal study.BMC geriatrics · 2026Article
- Time-to-event risk prediction of dual sensory loss in middle-aged patients with symptomatic knee osteoarthritis: model development, preliminary external validation, and explainability analysis.BMC medical informatics and decision making · 2026Article
- Trajectories of cognitive decline before and after new-onset dual sensory impairment: findings from two longitudinal studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Development and temporal validation of a prediction model for cognitive impairment in older adults with hearing loss based on the population health risk management framework.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aims to explore the cognitive trajectory changes in middle-aged and older adults individuals with dual sensory impairment (simultaneous visual and hearing impairment) and to identify the predictors of different trajectory changes. Methods: Based on the longitudinal data from the China Health and Retirement Longitudinal Study (CHARLS) from 2013 to 2020, data from 2,369 middle-aged and older adults individuals with dual sensory impairment were selected. A latent variable growth mixture model was constructed to analyze the cognitive function development trajectories in this population and to identify their predictive factors. Results: The cognitive function development trajectories in the middle-aged and older adults population can be categorized into three types: high cognitive level stable group, low cognitive level slowly declining group, and moderate cognitive level rapidly declining group. Logistic regression analysis showed that age (OR 30.544; 95% CI 9.35-99.754; Conclusion: There is group heterogeneity in the cognitive function development trajectories among middle-aged and older adults individuals with dual sensory impairment. Factors such as less than 4 h of nighttime sleep, low social participation, alcohol consumption, and lack of medical insurance are modifiable risk factors for cognitive decline in this population. Preventive strategies should be formulated accordingly, especially for vulnerable groups, including older rural residents and those with lower educational attainment, to prevent cognitive function deterioration in middle-aged and older adults individuals with dual sensory impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.